Phospho‑STAT1 expression as a potential biomarker for anti‑PD‑1/anti‑PD‑L1 immunotherapy for breast cancer
Yuko Nakayama(Fukushima Medical University), Koji Kono(Fukushima Medical University)
Cited by 62
Related Papers
<scp>PD</scp>‐L1 expression is mainly regulated by interferon gamma associated with <scp>JAK</scp>‐<scp>STAT</scp> pathway in gastric cancer
|Cancer Science|2017|320
miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair–Deficient Colorectal Cancer by Targeting PD-L1
|Molecular Cancer Research|2019|111
The MAPK Pathway Is a Predominant Regulator of HLA-A Expression in Esophageal and Gastric Cancer
|The Journal of Immunology|2013|90
PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms
|Scientific Reports|2021|57
Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer
|International Journal of Cancer|2014|55